Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

Background Off‐target properties of ticagrelor might reduce microvascular injury and improve clinical outcome in patients with ST‐segment–elevation myocardial infarction. The REDUCE‐MVI (Evaluation of Microvascular Injury in Revascularized Patients with ST‐Segment–Elevation Myocardial Infarction Tre...

Full description

Bibliographic Details
Main Authors: Nina W. van der Hoeven, Gladys N. Janssens, Henk Everaars, Alexander Nap, Jorrit S. Lemkes, Guus A. de Waard, Peter M. van de Ven, Albert C. van Rossum, Javier Escaned, Hernan Mejia‐Renteria, Tim J. F. ten Cate, Jan J. Piek, Clemens von Birgelen, Marco Valgimigli, Roberto Diletti, Niels P. Riksen, Nicolas M. Van Mieghem, Robin Nijveldt, Maarten A. H. van Leeuwen, Niels van Royen
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
endothelial function
microvascular injury
platelet inhibition
prasugrel
ST‐segment‐elevation myocardial infarction
ticagrelor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014411

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014411

Similar Items